The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The 55 STAR study: Prognostic and predictive value of the 55-gene classifier (55GC) in stage III colon cancer.
 
Toshiaki Ishikawa
Honoraria - Chugai Pharma; Daiichi Sankyo; Sanofi; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Takeda
 
Eiji Oki
Speakers' Bureau - Bayer Yakuhin; Chugai Pharma; Lilly Japan; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Eiji Shinto
No Relationships to Disclose
 
Mototsugu Shimokawa
Consulting or Advisory Role - Sysmex
 
Shigeki Yamaguchi
Speakers' Bureau - Chugai Pharma; Covidien; Johnson & Johnson; Lilly; Merck Serono; Taiho Pharmaceutical; TERUMO
 
Megumi Ishiguro
Honoraria - Merck Serono; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Taiho Pharmaceutical
Research Funding - Sysmex (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Seiji Hasegawa
No Relationships to Disclose
 
Yasumasa Takii
No Relationships to Disclose
 
Hideyuki Ishida
No Relationships to Disclose
 
Tetsuya Kusumoto
No Relationships to Disclose
 
Masaru Morita
No Relationships to Disclose
 
Naohiro Tomita
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)
 
Manabu Shiozawa
No Relationships to Disclose
 
Masafumi Tanaka
No Relationships to Disclose
 
Heita Ozawa
No Relationships to Disclose
 
Yojiro Hashiguchi
Honoraria - Bayer; Chugai Pharma; Kaken Pharmaceutical; Merck Serono; Sanofi; Taiho Pharmaceutical; Takeda
Research Funding - Chugai Pharma (Inst); Kaken Pharmaceutical (Inst); Merck Serono (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Shinobu Ohnuma
No Relationships to Disclose
 
Sachiyo Tada
Employment - Sysmex
Stock and Other Ownership Interests - Sysmex
 
Tomoko Matsushima
Employment - Sysmex
Stock and Other Ownership Interests - Sysmex
 
Kazuo Hase
No Relationships to Disclose